Quálitas Controladora. de Valuation
Is Q * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of Q * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Q * (MX$224.02) is trading above our estimate of fair value (MX$214.07)
Significantly Below Fair Value: Q * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for Q *?
Other financial metrics that can be useful for relative valuation.
What is Q *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | Mex$88.74b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.5x |
Enterprise Value/EBITDA | 14x |
PEG Ratio | 1.2x |
Price to Earnings Ratio vs Peers
How does Q *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 18.4x | ||
GNP * Grupo Nacional Provincial | 7.4x | n/a | Mex$31.3b |
BEZ Beazley | 5.3x | -4.6% | UK£4.4b |
NIACL New India Assurance | 43.7x | 41.1% | ₹407.3b |
SIGI Selective Insurance Group | 17.4x | 19.7% | US$6.2b |
Q * Quálitas Controladora. de | 21.6x | 18.6% | Mex$88.7b |
Price-To-Earnings vs Peers: Q * is expensive based on its Price-To-Earnings Ratio (21.6x) compared to the peer average (18.4x).
Price to Earnings Ratio vs Industry
How does Q *'s PE Ratio compare vs other companies in the South American Insurance Industry?
Price-To-Earnings vs Industry: Q * is expensive based on its Price-To-Earnings Ratio (21.6x) compared to the Global Insurance industry average (11.5x).
Price to Earnings Ratio vs Fair Ratio
What is Q *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 21.6x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate Q *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$224.02 | Mex$187.20 -16.4% | 14.0% | Mex$230.00 | Mex$160.00 | n/a | 5 |
Apr ’25 | Mex$196.12 | Mex$178.10 -9.2% | 17.5% | Mex$230.00 | Mex$133.60 | n/a | 6 |
Mar ’25 | Mex$194.14 | Mex$168.27 -13.3% | 14.4% | Mex$200.00 | Mex$133.60 | n/a | 6 |
Feb ’25 | Mex$189.95 | Mex$165.60 -12.8% | 15.5% | Mex$200.00 | Mex$133.60 | n/a | 6 |
Jan ’25 | Mex$171.58 | Mex$159.93 -6.8% | 12.5% | Mex$190.00 | Mex$133.60 | n/a | 6 |
Dec ’24 | Mex$163.89 | Mex$148.52 -9.4% | 11.9% | Mex$180.00 | Mex$133.00 | n/a | 5 |
Nov ’24 | Mex$148.61 | Mex$136.52 -8.1% | 6.6% | Mex$151.00 | Mex$124.00 | n/a | 5 |
Oct ’24 | Mex$130.95 | Mex$124.15 -5.2% | 13.0% | Mex$151.00 | Mex$99.00 | n/a | 6 |
Sep ’24 | Mex$133.85 | Mex$124.15 -7.2% | 13.0% | Mex$151.00 | Mex$99.00 | n/a | 6 |
Aug ’24 | Mex$122.97 | Mex$124.15 +1.0% | 13.0% | Mex$151.00 | Mex$99.00 | n/a | 6 |
Jul ’24 | Mex$127.02 | Mex$119.56 -5.9% | 14.7% | Mex$151.00 | Mex$92.00 | n/a | 7 |
Jun ’24 | Mex$117.81 | Mex$108.90 -7.6% | 13.0% | Mex$130.00 | Mex$91.40 | n/a | 6 |
May ’24 | Mex$118.85 | Mex$108.90 -8.4% | 13.0% | Mex$130.00 | Mex$91.40 | Mex$224.02 | 6 |
Apr ’24 | Mex$115.29 | Mex$105.57 -8.4% | 15.5% | Mex$130.00 | Mex$80.00 | Mex$196.12 | 6 |
Mar ’24 | Mex$115.49 | Mex$103.40 -10.5% | 15.0% | Mex$130.00 | Mex$80.00 | Mex$194.14 | 6 |
Feb ’24 | Mex$105.43 | Mex$98.23 -6.8% | 12.0% | Mex$110.00 | Mex$75.00 | Mex$189.95 | 6 |
Jan ’24 | Mex$85.92 | Mex$97.07 +13.0% | 13.0% | Mex$110.00 | Mex$75.00 | Mex$171.58 | 6 |
Dec ’23 | Mex$85.18 | Mex$101.77 +19.5% | 16.8% | Mex$129.00 | Mex$75.00 | Mex$163.89 | 7 |
Nov ’23 | Mex$84.24 | Mex$103.43 +22.8% | 16.0% | Mex$129.00 | Mex$75.00 | Mex$148.61 | 8 |
Oct ’23 | Mex$83.05 | Mex$106.05 +27.7% | 12.6% | Mex$129.00 | Mex$85.00 | Mex$130.95 | 8 |
Sep ’23 | Mex$88.00 | Mex$111.50 +26.7% | 8.4% | Mex$129.00 | Mex$98.00 | Mex$133.85 | 8 |
Aug ’23 | Mex$85.07 | Mex$111.38 +30.9% | 8.6% | Mex$129.00 | Mex$97.00 | Mex$122.97 | 8 |
Jul ’23 | Mex$92.31 | Mex$114.25 +23.8% | 7.7% | Mex$129.00 | Mex$97.00 | Mex$127.02 | 8 |
Jun ’23 | Mex$101.23 | Mex$116.13 +14.7% | 4.1% | Mex$124.00 | Mex$106.00 | Mex$117.81 | 8 |
May ’23 | Mex$110.00 | Mex$117.89 +7.2% | 3.0% | Mex$124.00 | Mex$112.10 | Mex$118.85 | 8 |
Analyst Forecast: Target price is lower than the current share price.